Current Studies

Urine, vaginal and endocervical swab collection study to test a device for the detection of Chlamydia (CT), Gonorrhea (NG) and Trichomonas (TV).

ELIGIBILITY:       

• FEMALE PATIENTS 18 years and older
• Symptomatic or asymptomatic (i.e. table visits: problems, well women, etc.)
• NOT pregnant, 
• NOT had a pap within the last 2 months

Urine and vaginal swab collection study to test a device for the detection of Chlamydia (CT) and Gonorrhea (NG).

ELIGIBILITY:       

• FEMALE AND MALE PATIENTS 18 years and older
• Symptomatic or asymptomatic (i.e. table visits: problems, well women, etc.)
• NOT pregnant

Endocervical swab for development of HPV assay.

• Eligibility:
  • 25 - 65 Year old females
  • Must not be pregnant
  • Must have abnormal PAP results in the past <18 months, and no follow-up treatment.

Follow-up visits to assess the safety of Mirena in subjects who have Mirena for 5 years or more.

• Eligibility:
  • Women 18 to 35 years 
  • Currently using a Mirena for contraception or for contraception and heavy menstrual bleeding
  • Who have had the Mirena in situ for at least 4 years and 6 months but no longer than 5 years (at visit 2)
  • Are willing to continue its use for contraception or contraception and heavy menstrual bleeding for up to 8 years in total.

Efficacy trial of Amphora gel for the prevention of acquisition of urogenital Chlamydia trachomatis infection.

• Eligibility:
  • Female subjects between 18 and 35 years
  • Negative pregnancy test
  • Agree to use an approved method of contraception
  • Reports sexual intercourse with a male partner at least 3 times per month in the previous month and anticipates sexual intercourse regularly for the duration of the study
  • Agree to abstain from douching or any form of vaginal suppository use (other than study product) during course of study